Brit J Cancer:青少年动物产品摄入量与前列腺癌风险和死亡率之间的关系

2021-06-16 MedSci原创 MedSci原创

该研究的结果证据表明,青少年期未加工牛肉摄入量,或可能为牛肉摄入量,与前列腺癌风险和死亡率降低相关。需要进一步研究早期暴露信息,以更好地了解这种关联。

尽管前列腺癌是美国男性中最常的癌症,也是癌症死亡的第二大原因,但对其病因知之甚少,对其预防策略也知之甚少。

已有研究指出青少年期摄入动物产品会促进前列腺癌的发展,因为其潜在的致癌成分和对青春期激素水平会产生影响。

近日,肿瘤学领域权威杂志British Journal of Cancer上发表了一篇研究文章,研究人员使用来自NIH-AARP饮食与健康研究的159482名参与者的数据,以调查青少年在12-13岁时的红肉(未加工牛肉和加工红肉)、家禽、鸡蛋、金枪鱼罐头、动物脂肪和动物蛋白摄入量与随后14年间随访过程中发生前列腺癌风险和死亡率之间的相关性。Cox比例风险回归用于计算总(n=17349)、晚期 (n=2297) 和致命性(n=804)前列腺癌的风险比(HR)和95%置信区间(CI)。

前列腺癌的HR和95%CI

研究人员观察到青少年期未加工牛肉摄入量与总的、晚期和致命性前列腺癌风险之间存在负相关性趋势(多变量调整后,分别有趋势P=0.01、0.02和0.04)。

由此可见,该研究的结果证据表明,青少年期未加工牛肉摄入量,或可能为牛肉摄入量,与前列腺癌风险和死亡率降低相关。需要进一步研究早期暴露信息,以更好地了解这种关联

原始出处:

Tuo Lan.et al.Adolescent animal product intake in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.Brit J Cancer.2021.https://www.nature.com/articles/s41416-021-01463-1

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2022-01-07 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-09-03 lmm397
  4. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-17 走,走走

    吃素还是有道理的

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-17 ms2000000321551178

    好遇到了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2062018, encodeId=cac52062018de, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Jan 07 03:33:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022593, encodeId=6d002022593e5, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Wed Dec 08 02:33:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860704, encodeId=15a11860e0418, content=<a href='/topic/show?id=830b5693631' target=_blank style='color:#2F92EE;'>#摄入量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56936, encryptionId=830b5693631, topicName=摄入量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Fri Sep 03 09:33:45 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974357, encodeId=9e8d9e4357f8, content=吃素还是有道理的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Thu Jun 17 12:10:24 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974261, encodeId=14419e4261d0, content=好遇到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/fa4612eb12f143479ad6386fc46b5c01/5c4dee449125404cb5fe5ac986cc5d99.jpg, createdBy=f2715482687, createdName=ms2000000321551178, createdTime=Thu Jun 17 06:19:57 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041026, encodeId=0534104102664, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jun 16 22:33:45 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 misszhang

    前列腺癌相关研究,学习了,谢谢梅斯

    0

相关资讯

Eur Urol:盆腔淋巴结转移的预测:一项国际多中心研究

在局部前列腺癌(PCa)患者中,机器人辅助前列腺根治术(RARP)已经成为最常见的治愈性手术治疗方案。扩展盆腔淋巴结清扫术(ePLND)是存在盆腔淋巴结转移(pN1疾病)分期方法的金标准,国际临床实践

ASCO 2021: 放射肿瘤学变革下一个浪潮:放射药物追踪并杀死癌细胞

放射肿瘤学变革,医生报告称,接受了一种直接向肿瘤细胞提供辐射的实验性药物的晚期前列腺癌男性的生存率有所提高。

BJU Int:前列腺切除术和盆腔淋巴结清扫术后淋巴囊肿明显减少

目前欧洲泌尿外科协会(EAU)的前列腺癌(PCa)指南建议,当估计的淋巴结阳性风险超过5%时,应对高风险和中风险患者进行扩展盆腔淋巴结清扫(ePLND)。事实上,尽管ePLND有着较高的并发症发生率,

JCO:高复发/死亡风险的前列腺癌患者根治性切除术后或可采用辅助放疗巩固

pN1期或pGleason评分8-10分和pT3/4期的前列腺癌患者,或可考虑采用辅助放射治疗,有望显著降低其全因死亡风险

Radiology:多参数MRI在术前预测前列腺外侵犯中的应用

前列腺外侵犯(EPE)与男性前列腺癌根治性切除术后的手术切缘阳性、局部复发和生存率相关。由于EPE是否存在可影响手术时神经血管束的保留,因此EPE的术前预测意义重大。

Eur Urol Oncol:雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌

局部前列腺癌患者根治性前列腺切除术后的生化复发(BCR)率为15-30%,其中三分之一的患者在常规影像学上有可见病变。尽管放射治疗(RT)加上或不加上雄激素阻断治疗(ADT)可以治愈一部分患者,但治疗